E Fund Management Co., Ltd.
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1842296
GUANGZHOU, F4
Position in CRVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$171,675
-$35,427 QoQ
Shares Held
11,491
-18.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#128
of 172 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. CRVS ranks #83 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,455 | $5,690,042 | |
| 2 | ERAS |
Erasca, Inc.
|
265,381 | $4,861,779 | |
| 3 | CELC |
Celcuity Inc.
|
45,895 | $4,801,534 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,774 | $4,730,068 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
109,328 | $3,798,054 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,158 | $3,216,219 | |
| 7 | LEGN |
Legend Biotech Corp
|
109,327 | $3,157,363 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,073 | $1,828,155 |
All Filings in CRVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,675 | 11,491 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $207,102 | 14,156 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||